Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer.
A family history can be a valuable tool in the era of precision medicine. Although a few studies have described an association of family history of lung cancer with EGFR activating mutation, their impact on survival of lung cancer patients is unclear.The study included consecutive 829 non-small-cell...
Main Authors: | Jung Soo Kim, Min Seong Cho, Jong Hyeon Nam, Hyun-Jung Kim, Kyeng-Won Choi, Jeong-Seon Ryu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5423629?pdf=render |
Similar Items
-
Gender as an independent prognostic factor in small-cell lung cancer: Inha Lung Cancer Cohort study using propensity score matching.
by: Jun Hyeok Lim, et al.
Published: (2018-01-01) -
Prognostic value of quantitative measurement of EGFR mutation using peptide nucleic acid clamping in advanced EGFR mutant non‐small cell lung cancer patients
by: Insu Kim, et al.
Published: (2019-07-01) -
Small-cell lung cancer presenting as fatal pulmonary hemorrhage
by: Lim Jun Hyeok, et al.
Published: (2018-03-01) -
Dramatic response of acute disseminated intravascular coagulation to erlotinib in a patient with lung adenocarcinoma with activating mutation
by: Jung Soo Kim, et al.
Published: (2018-01-01) -
Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study.
by: Hee-Young Yoon, et al.
Published: (2020-01-01)